Tsujita, Kenichi
Sugiyama, Seigo
Sumida, Hitoshi
Shimomura, Hideki
Yamashita, Takuro
Yamanaga, Kenshi
Komura, Naohiro
Sakamoto, Kenji
Oka, Hideki
Nakao, Koichi
Nakamura, Sunao
Ishihara, Masaharu
Matsui, Kunihiko
Sakaino, Naritsugu
Nakamura, Natsuki
Yamamoto, Nobuyasu
Koide, Shunichi
Matsumura, Toshiyuki
Fujimoto, Kazuteru
Tsunoda, Ryusuke
Morikami, Yasuhiro
Matsuyama, Koushi
Oshima, Shuichi
Kaikita, Koichi
Hokimoto, Seiji
Ogawa, Hisao
Funding for this research was provided by:
Sanofi
Daiichi-Sankyo
Meso Scale Diagnostics
Dainippon Sumitomo Pharma
Takeda Pharmaceutical Company
Shionogi
Kowa Company
Novartis
Ministry of Education, Culture, Sports, Science and Technology
AstraZeneca
Bayer
Pfizer
Astellas Pharma US
Otsuka America
This article is maintained by: Elsevier
Article Title: Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention
Journal Title: Journal of the American College of Cardiology
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.jacc.2015.05.065
Content Type: article
Copyright: Copyright © 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.